Load Experienced While Using a Stander in Children With Cerebral Palsy
NCT ID: NCT01952496
Last Updated: 2016-02-17
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
3 participants
INTERVENTIONAL
2014-02-28
2015-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Quantifying Patient-Specific Changes in Neuromuscular Control in Cerebral Palsy
NCT02699554
Effects of Standing on Non-Ambulatory Children With Neuromuscular Conditions
NCT02428673
Augmenting Ankle Plantarflexor Function in Cerebral Palsy
NCT05154253
Ankle Foot Orthosis on Muscle Activity in Cerebral Palsy
NCT06291974
Quantifying Energetic Demands of Walking for People With Cerebral Palsy
NCT04303078
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Force-measuring platform
A force-measure platform will be placed under each foot of the subject to record the time course of load borne by each of the lower extremities during weight-bearing training in an assisted standing device.
Intervention: Assisted Standing Treatment Program. Assisted standing treatment program will include at least 2 hours a day, 5 days a week (a total of at least 10 hours a week) for a period of \~9 months.
Assisted Standing Treatment Program
Assisted standing treatment program will include at least 2 hours a day, 5 days a week (a total of at least 10 hours a week) for a period of \~9 months.
Arm: Force-measuring platform
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Assisted Standing Treatment Program
Assisted standing treatment program will include at least 2 hours a day, 5 days a week (a total of at least 10 hours a week) for a period of \~9 months.
Arm: Force-measuring platform
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Diagnosed with Cerebral Palsy (CP)
3. Treated at Gillette Children's Specialty Healthcare
4. Gross Motor Function Classification System level of IV or V (non-ambulatory without assistance)
5. Participating in a standing program using a stationary assisted standing device
6. Parent/Guardian willing and able to give consent
Exclusion Criteria
17 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Minnesota
OTHER
Gillette Children's Specialty Healthcare
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Walter Truong, MD
Role: PRINCIPAL_INVESTIGATOR
Gillette Children's Specialty Healthcare
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Clinical and Translational Science Institute at University of Minnesota
Minneapolis, Minnesota, United States
Gillette Children's Specialty Healthcare
Saint Paul, Minnesota, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
1308M40341
Identifier Type: OTHER
Identifier Source: secondary_id
15994
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.